HepatologyStrategicLead

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems. Our diverse portfolio consists of vaccines, specialty medicines, and general medicines. Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges. We are seeking an experienced and passionate professional to lead pre-launch activities for a non-authorized hepatitis brand and hepatology pipelines, aligned with the government’s goal of eliminating Hepatitis B. This high-impact role requires an individual with expertise in public health strategy, stakeholder engagement, advocacy, and pre-market development planning. You will work closely with policymakers, healthcare experts, and decision-makers to ensure successful preparation for product introduction while advancing disease elimination efforts. **Key Responsibilities:** **1\. Pre-Launch Strategy Development** * Design and implement a comprehensive pre-launch plan for the hepatitis brand, focusing on market readiness, landscape shaping, and stakeholder alignment. * Collaborate with cross-functional teams (market access, medical affairs, government affairs, finance etc.) to create anticipatory frameworks and tools for launch-stage execution. **2\. Policy Advocacy and Government Engagement** * Build strong relationships with KOL, policymakers and government health agencies, aligning brand strategies with national hepatitis elimination priorities. * Contribute to shaping policies and initiatives aimed at implementing effective screening, prevention,